Hanchung Medical has launched Etherics 100mg PLLA, a collagen stimulator based on PLLA (poly-L-lactic acid).

According to the company, PLLA stimulates fibroblasts in aging skin to promote collagen production and gradually biodegrades within the body, helping to temporarily improve facial wrinkles over time.

Key product information includes a recommended treatment interval of 4–6 weeks, an expected duration of 18 to 24 months (subject to individual variation), a storage temperature of 1–30°C, and a shelf life of 36 months. Etherics 100mg PLLA is supplied in a 100mg / 1 vial configuration. 

A representative from Hanchung Medical stated,
“Etherics 100mg PLLA induces the skin’s natural collagen production, delivering increasingly natural-looking results over time. We aim to provide a broad range of solutions that can be tailored to individual skin concerns.”

This launch follows the release of Etherics 200mg PDLLA in October 2024.
Through its dual lineup of PDLLA 200mg and PLLA 100mg, Hanchung Medical expands treatment options across a wide range of indications, from volume enhancement to improvements in skin texture and contour.